New diketopiperazine derivatives
Q Zhang et al
3
5
˚
ꢀ3
Fr.1-5 (1.42 g) was subjected to silica gel column (100–200 mesh) and was and largest difference peak and hole, 0.206 and ꢀ0.230 e.A . Crystallographic
eluted with petroleum ether/ethyl acetate (100/0, 100/10, 100/20, v/v, each of data (excluding structure factors) for compound 1 in this paper have been
1
00ml) to give three subfractions: Fr.1-5-1 (100/0, v/v), Fr.1-5-2 (100/10, v/v) deposited with the Cambridge Crystallographic Data Center as supplementary
and Fr.1-5-3 (100/20, v/v). The elutions from petroleum ether/ethyl acetate publication number CCDC 888963. Copies of the data can be obtained free of
100/30, 100 ml) were collected with 10ml each and combined on the basis of charge on application to CCDC.
TLC analysis to give four subfractions Fr.1-5-4–Fr.1-5-7. Fr.1-5-4 (87.2 mg) 3-Benzylpiperazine-6-(4-methoxybenzylidene)-2,5-dione (a mixture of
was purified by semipreparative HPLC (YMC*GEL ODS-A, 120 A S-5 mm, nocazine D (2a, 6R) and nocazine E (2b, 6S)): white powder, UV/vis (in
(
2
2
50 ꢁ 10mm ; solvent A, 0.1% formic acid in water; solvent B, 90%
CH3OH) lmax nm (log e): 204 (3.85), 311 (3.44)nm, ESI-MS m/z 345.1
þ
ꢀ
acetonitrile in water; eluted with constant 85% solvent B) to obtain compound [Mþ Na]
,
321.3 [MꢀH] , HRFABMS m/z 345.1215 (calcd. for
þ
1
(8.2mg). Fr.1-5-7 (185.5mg) was purified by semipreparative HPLC C H N O Na [M þ Na]
, 345.1215; see Table 1 and Supplementary
1
9 18 2 3
2
1
13
(YMC*GEL ODS-A, 120 A S-5 mm, 250 ꢁ 10mm ; solvent A, 0.1% formic Figure S3 for H and C NMR data.
acid in water; solvent B, 90% acetonitrile in water, eluted with constant 70%
(S, Z)-3-Benzylidene-6-methylpiperazine-2,5-dione (3): white powder,
nm (log e): 219 (4.52), 292 (3.75)nm, ESI-MS m/
solvent B) to obtain the compounds 5 (10.1 mg) and 6 (3.6mg). Fr.3 was UV/vis (in CH OH) l
3
max
þ
ꢀ
subjected to Sephadex LH-20 chromatography and was eluted with CHCl3/ z 217.4 [M þ H] , 215.1 [MꢀH] ; HRFABMS m/z 215.0817 (calcd. for
ꢀ
CH3OH (1:1) to give two subfractions (Fr.3-1 and Fr.3-2). Fr.3-2 (1.79 g) was
separated by silica gel column chromatography (100–200 mesh) and was eluted Table 1 and Supplementary Figure S4 for H and C NMR data.
C12H11N2O2 [MꢀH] , 215.0815); [a]21D¼ ꢀ2391 (c ¼ 0.14, CH3OH); see
1
13
with CHCl /CH OH (30:1) to give two subfractions (Fr.3-1-1 and Fr.3-1-2).
3
(S, Z)-3-Benzylidene-6-isopropylpiperazine-2,5-dione (4): white needle
crystal, UV/vis (in CH3OH) lmax nm (log e): 224 (3.65), 296 (3.74)nm,
3
Fr.3-1-2 (531 mg) was separated by normal phase silica gel column chromato-
graphy (100–200 mesh) and was eluted with petroleum ether/ethyl acetate ESI-MS m/z 267.3 [M þ Na] , 245.2 [Mþ H] , 243.2 [MꢀH] , HRFABMS
þ
þ
ꢀ
þ
21
(100/0, 100/10, 100/20, 100/30) to give four subfractions (Fr.3-1-2-1–Fr.3-1-2-4).
m/z 245.1294 (calcd. for C14H17N2O2 [Mþ H] , 245.1290), 267.1115 (calcd.
þ
Fr.3-1-2-2 (90.2 mg), Fr.3-1-2-3 (111 mg) and Fr.3-1-2-4 (18.1 mg) were further for C H N O Na, [M þ Na] , 267.1109); [a] ¼ ꢀ2.51 (c ¼ 0.08, CH OH);
14
16
2
2
D
3
1
purified by semipreparative HPLC (YMC*GEL ODS-A, 120 A S-5mm, see Supplementary Figure S5 for H NMR data.
2
2
50 ꢁ 10mm ; solvent A, 0.1% formic acid in water; solvent B, 90%
(3Z, 6Z)-3-(4-Methoxybenzylidene)-6-(2-methylpropylidene)piperazine-
þ
acetonitrile in water) to yield compounds 2 (3.4mg) from Fr.3-1-2-2 (eluted 2,5-dione (5): white needle crystal, ESI-MS m/z 309.2 [Mþ Na] , 285.3
ꢀ
1
13
with constant 50% solvent B), 3 (6.7mg) from Fr.3-1-2-3 (eluted with constant [MꢀH] ; see Supplementary Figure S6 for H and C NMR data.
þ
50% solvent B) and 4 (2.6mg) from Fr.3-1-2-4 (eluted with constant 55%
solvent B), respectively.
XR334 (6): yellow powder, ESI-MS m/z 321.1 [M þ H] , 343.1 [Mþ
þ
1
13
Na] ; see Supplementary Figure S7 for H and C NMR data.
-Methoxynaphthalene-1,4-dione (7): yellow powder, ESI-MS m/z 211.2
2
Mþ H] , 243.2 [Mþ Na] þ ; see Supplementary Figure S8 for H and 13C
þ
1
[
NMR data.
Determining the absolute configuration of amino acids in
compounds 2–4 by Marfey’s method
1
-Hydroxy-4-methoxy-2-naphthoic acid (8): brown powder, ESI-MS m/z
þ
The FDAA derivatized hydrolysates of compounds 2 (0.50 mg), 3 (0.50 mg)
and 4 (0.58 mg), and the standard amino acids were prepared according to the
published method.24 The FDAA derivatives were then subjected to HPLC
ꢀ
1
2
41.0 [Mþ Na] , 217.1 [MꢀH] ; see Supplementary Figure S9 for H and
1
3
C NMR data.
2
analysis (Luna C18 column; 5 mm, 4.6 ꢁ 150 mm ) using the following solvent
system: solvent A, 10% acetonitrile in water supplementing with 0.1% formic Biological activity
acid; solvent B, 90% acetonitrile in water. The HPLC program for detecting Antibacterial activities were evaluated against bacterial strains S. aureus ATCC
FDAA derivatives of compounds 2 and 4 was set as: 5–100% solvent B 29213, Enterococcus faecalis ATCC 29212, B. subtilis SCSIO BS01 and
(
(
0–20min, linear gradient), 100% solvent B (20–23min), 100–5% solvent B B. thuringiensis SCSIO BT01 according to previously described methods.36
23–24 min) and 5% solvent B (24–30 min). The HPLC program for detecting Cytotoxic activities were determined against three tumor cell lines, including
FDAA derivatives of compound 3 was set as: 5–55% solvent B (0–20 min, MCF-7 cells (human breast adenocarcinoma cell line), NCI-H460 (human
linear gradient), 55–100% solvent B (20–24 min), 100% solvent B (24–25 min), non-small cell lung cancer cell line) and SF-268 (human glioma cell line),
5
–100% solvent B (25–26 min) and 5% solvent B (26–30min). The flow rate according to published protocols.37
ꢀ1
was set at 1 ml min with UV detection at l ¼ 340 nm.
ACKNOWLEDGEMENTS
Chiral analysis of compound 2
The solution of 2 in methanol was subjected to HPLC analysis (Chiralpak
This study was supported in part by the Chinese Academy of Sciences for Key
Topics in Innovation Engineering (KZCX2-YW-JC202), the Ministry of
Science and Technology of China (2012AA092104, 2010CB833805) and the
National Science Foundation of China (41006089, 41106143, 31125001). CZ is
a scholar of the ‘100 Talents Project’ of the Chinese Academy of Sciences
2
AD-H, 250ꢁ 4.6 mm , ID 5 mm) (Daicel Chemicals) on an Agilent 1200
series HPLC system, eluted with 20% 2-propanol in n-hexane, UV detection
at l ¼ 254 nm.
Methoxyneihumicin (1): yellow needle crystal, UV/vis (in CH3OH) lmax
nm (log e): 202 (3.96), 227 (3.76), 310 (3.68)nm, ESI-MS m/z 357.0 [Mþ
(
08SL111002). This study was funded by the Natural Science Funds of South
China Sea Institute of Oceanology for Young Scholar (SQ200903). We are
grateful to analytical facilities in the South China Sea Institute of Oceanology.
þ
ꢀ
Na] , 333.1 [MꢀH] , HRFABMS m/z 335.1393 (calcd. for C20H19N2O3
þ
1
[
Mþ H] , 335.1396), see Table 1 and Supplementary Figure S2 for H NMR
and 13C NMR. X-ray crystal structure analysis of compound 1: Yellow needle
˚
crystal, C H N O , M ¼ 334.36, T ¼ 150(2) K, l ¼ 1.54178 A; crystal system,
20 18 2 3
˚
˚
monoclinic, space group P 1 21/c 1, a ¼ 6.39230(10) A, b ¼ 14.9704(3)A,
1
2
3
4
5
Goodfellow, M. & Fiedler, H. P. A guide to successful bioprospecting: informed by
actinobacterial systematics. Antonie Van Leeuwenhoek 98, 119–142 (2010).
Baltz, R. H. Renaissance in antibacterial discovery from actinomycetes. Curr. Opin.
Pharmacol. 8, 557–563 (2008).
Bull, A. T. & Stach, J. E. Marine actinobacteria: new opportunities for natural product
search and discovery. Trends Microbiol. 15, 491–499 (2007).
Pathom-Aree, W. et al. Diversity of actinomycetes isolated from Challenger Deep
sediment (10,898 m) from the Mariana Trench. Extremophiles 10, 181–189 (2006).
Tian, X. P. et al. Marinactinospora thermotolerans gen. nov., sp. nov., a marine
actinomycete isolated from a sediment in the northern South China Sea. Int. J. Syst.
Evol. Microbiol. 59, 948–952 (2009).
˚
˚ 3
c ¼ 16.7559(3) A, a ¼ 901, b ¼ 91.785(2)1, g ¼ 901, V ¼ 1602.68(5) A , Z ¼ 4,
ꢀ3
ꢀ1
Dc¼ 1.386 Mgm ; absorption coefficient, 0.766 mm , F(000)¼ 704; and
3
crystal size, 0.43ꢁ 0.33ꢁ 0.22mm . Theta range for data collection, 3.96–
6
7.011; index ranges, ꢀ7php5, ꢀ17pkp17, ꢀ19plp20; reflections
collected, 9663; independent reflections, 2858 (R (int) ¼ 0.0165); completeness
to theta ¼ 67.011, 99.8%; absorption correction, semi-empirical from equiva-
lents; maximum and minimum transmission, 0.8496 and 0.7343; refinement
2
method, full-matrix least-squares on F ; data/restraints/parameters, 2858/0/
2
2
28; goodness-of-fit on F , 1.042; NFinal R indices (I42 sigma (I)),
6
Tian, X. P. et al. Streptomyces nanshensis sp. nov., isolated from the Nansha Islands in
the South China Sea. Int. J. Syst. Evol. Microbiol. 59, 745–749 (2009).
R1¼ 0.0342, wR2 ¼ 0.0856; R indices (all data), R1¼ 0.0376, wR2 ¼ 0.0882;
The Journal of Antibiotics